ALNY |
Alnylam Pharmaceuticals, Inc. |
31.59B |
7.43% |
|
|
|
|
|
244.89 |
-0.77% |
44.09% |
28.75% |
---|
RNA |
Avidity Biosciences, Inc. |
5.16B |
5.90% |
|
|
|
|
|
43.25 |
1.62% |
54.73% |
10.98% |
---|
NTRA |
Natera, Inc. |
22.08B |
5.12% |
|
|
|
|
|
167.26 |
-1.24% |
44.98% |
23.28% |
---|
BNTX |
BioNTech SE |
27.12B |
4.86% |
|
|
|
|
|
113.13 |
4.53% |
44.51% |
53.51% |
---|
VCYT |
Veracyte, Inc. |
3.07B |
4.71% |
|
|
|
|
|
39.59 |
1.67% |
67.02% |
27.40% |
---|
RARE |
Ultragenyx Pharmaceutical Inc. |
4.36B |
4.48% |
|
|
|
|
|
47.24 |
2.65% |
62.98% |
24.90% |
---|
ILMN |
Illumina, Inc. |
22.23B |
4.46% |
|
|
|
|
|
140.14 |
2.30% |
36.71% |
15.88% |
---|
TECH |
Bio-Techne Corporation |
11.33B |
4.19% |
|
|
|
|
|
71.28 |
0.32% |
31.76% |
31.60% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
10.91B |
3.94% |
|
|
|
|
|
114.23 |
3.38% |
39.79% |
4.97% |
---|
QGEN |
Qiagen N.V. |
9.49B |
3.78% |
|
|
|
|
|
42.78 |
1.06% |
37.43% |
62.65% |
---|
LEGN |
Legend Biotech Corporation |
7.51B |
3.78% |
|
|
|
|
|
40.94 |
2.99% |
63.53% |
45.67% |
---|
A |
Agilent Technologies, Inc. |
38.46B |
3.59% |
|
|
|
|
|
133.84 |
1.35% |
36.45% |
70.24% |
---|
MYGN |
Myriad Genetics, Inc. |
1.41B |
3.55% |
|
|
|
|
|
15.49 |
2.45% |
31.73% |
25.62% |
---|
CRSP |
CRISPR Therapeutics AG |
4.09B |
3.31% |
|
|
|
|
|
47.88 |
3.43% |
54.15% |
16.79% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.30B |
3.22% |
|
|
|
|
|
18.54 |
1.42% |
67.97% |
66.30% |
---|
1548.HK |
GENSCRIPT BIOTECH CORP |
|
3.12% |
|
|
|
|
|
|
|
|
|
---|
BMRN |
BioMarin Pharmaceutical Inc. |
12.25B |
2.88% |
|
|
|
|
|
64.26 |
1.28% |
31.89% |
30.84% |
---|
BEAM |
Beam Therapeutics Inc. |
2.07B |
2.79% |
|
|
|
|
|
25.05 |
6.23% |
82.04% |
73.89% |
---|
RCKT |
Rocket Pharmaceuticals, Inc. |
1.29B |
2.70% |
|
|
|
|
|
14.11 |
10.32% |
80.83% |
58.32% |
---|
NTLA |
Intellia Therapeutics, Inc. |
1.46B |
2.62% |
|
|
|
|
|
14.30 |
3.62% |
79.69% |
48.27% |
---|
GILD |
Gilead Sciences, Inc. |
112.40B |
2.47% |
|
|
|
|
|
90.19 |
0.48% |
24.72% |
31.19% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
116.14B |
2.19% |
|
|
|
|
|
450.97 |
0.13% |
48.14% |
95.50% |
---|
TXG |
10x Genomics, Inc. |
1.73B |
2.16% |
|
|
|
|
|
14.31 |
7.67% |
67.80% |
30.55% |
---|
CDNA |
CareDx, Inc |
1.24B |
2.06% |
|
|
|
|
|
23.13 |
2.44% |
83.70% |
26.36% |
---|
MRNA |
Moderna, Inc. |
15.82B |
1.90% |
|
|
|
|
|
41.11 |
7.48% |
81.70% |
86.36% |
---|
VIR |
Vir Biotechnology, Inc. |
980.57M |
1.26% |
|
|
|
|
|
7.12 |
2.45% |
72.98% |
63.63% |
---|
PACB |
Pacific Biosciences of California, Inc. |
492.96M |
0.98% |
|
|
|
|
|
1.8000 |
1.69% |
97.24% |
31.08% |
---|
SANA |
Sana Biotechnology, Inc. |
582.73M |
0.84% |
|
|
|
|
|
2.6100 |
11.06% |
219.93% |
41.11% |
---|
RGNX |
REGENXBIO Inc. |
475.14M |
0.74% |
|
|
|
|
|
9.59 |
4.47% |
129.53% |
41.60% |
---|
FLGT |
Fulgent Genetics, Inc. |
546.59M |
0.74% |
|
|
|
|
|
17.87 |
5.43% |
43.52% |
49.06% |
---|
VERV |
Verve Therapeutics, Inc. |
410.62M |
0.60% |
|
|
|
|
|
4.85 |
5.43% |
209.02% |
60.83% |
---|
4974.T |
TAKARA BIO INC |
|
0.56% |
|
|
|
|
|
|
|
|
|
---|
ALLO |
Allogene Therapeutics, Inc. |
463.38M |
0.54% |
|
|
|
|
|
2.2100 |
4.74% |
189.23% |
43.61% |
---|
QURE |
uniQure N.V. |
281.74M |
0.51% |
|
|
|
|
|
5.78 |
-1.11% |
108.88% |
67.43% |
---|
EDIT |
Editas Medicine, Inc. |
201.42M |
0.46% |
|
|
|
|
|
2.4400 |
2.95% |
195.55% |
79.04% |
---|
TSVT |
2seventy bio, Inc. |
185.91M |
0.42% |
|
|
|
|
|
3.61 |
14.24% |
309.54% |
26.87% |
---|
PSTX |
Poseida Therapeutics, Inc. |
266.08M |
0.33% |
|
|
|
|
|
2.7300 |
0.74% |
298.64% |
30.85% |
---|
CRBU |
Caribou Biosciences, Inc. |
182.92M |
0.28% |
|
|
|
|
|
2.0200 |
2.02% |
130.40% |
17.48% |
---|
LYEL |
Lyell Immunopharma, Inc. |
265.26M |
0.21% |
|
|
|
|
|
0.9500 |
3.64% |
386.53% |
100.00% |
---|
BLUE |
bluebird bio, Inc. |
68.07M |
0.17% |
|
|
|
|
|
0.3501 |
17.52% |
426.24% |
46.13% |
---|
GRAL |
GRAIL INC |
|
0.07% |
|
|
|
|
|
|
|
|
|
---|
E |
Eni S.p.A. |
46.14B |
0.01% |
|
|
|
|
|
29.01 |
0.42% |
127.04% |
47.63% |
---|